Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment | ACS Nano
![Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial | Trials | Full Text Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3548-4/MediaObjects/13063_2019_3548_Fig1_HTML.png)
Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial | Trials | Full Text
![Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses - eClinicalMedicine Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses - eClinicalMedicine](https://www.thelancet.com/cms/asset/4a7fb05a-e5f5-449c-a8b6-8d6d6b0f44a0/gr1.jpg)
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses - eClinicalMedicine
![Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/b32557d7-ae42-4d17-880b-65578b52eabe/gr1.gif)
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology
![PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors](https://i1.rgstatic.net/publication/322894972_P374_Non-alcoholic_fatty_liver_disease_in_inflammatory_bowel_disease_Prevalence_and_risk_factors/links/5ac8d953a6fdcc8bfc823559/largepreview.png)
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - ScienceDirect Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1590865821008562-gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - ScienceDirect
![PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease](https://i1.rgstatic.net/publication/350133906_ECCO_Guidelines_on_the_Prevention_Diagnosis_and_Management_of_Infections_in_Inflammatory_Bowel_Disease/links/60530eeb92851cd8ce4bd73b/largepreview.png)
PDF) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
![Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review | Advances in Therapy Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review | Advances in Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-023-02457-6/MediaObjects/12325_2023_2457_Fig1b_HTML.png)
Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review | Advances in Therapy
![Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease - Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch, 2021 Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease - Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch, 2021](https://journals.sagepub.com/cms/10.1177/17562848211004839/asset/images/large/10.1177_17562848211004839-fig1.jpeg)
Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease - Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch, 2021
![Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis - eClinicalMedicine Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/c4e601fc-df88-4907-a54c-4b46c833cd90/gr1.jpg)
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis - eClinicalMedicine
![Frontiers | Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease Frontiers | Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease](https://www.frontiersin.org/files/Articles/705342/fimmu-12-705342-HTML/image_m/fimmu-12-705342-g001.jpg)
Frontiers | Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease
![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO.jpg)